Marko Popovic
@PopovicMM
Followers
360
Following
181
Media
4
Statuses
149
Retina Specialist @unityhealthTO, Medical Retina Fellowship @ucla, Ophthalmology Residency @uoftpgme, MPH @HarvardChanSPH, MD @uoftmedicine, BHSc @MacHealthSci
Toronto, Canada
Joined December 2020
DeepSeek-R1 demonstrated superior performance compared to #OpenAI o1 in clinical diagnosis and management across subspecialties, while also reducing operating costs. https://t.co/FomIrl2uTw
@DanielMiladMD @FaresAntaki @theMichaelBalas @pearsekeane
0
4
10
#TemertyMed study finds patients with diabetes-related eye disease who are male, Black or Hispanic, or live farther away are more likely to miss follow-up, raising risk of vision loss. https://t.co/oJGbOzOKYY
6
4
7
LARGE RETINAL CAPILLARY ANEURYSM A Delphi Consensus Study and Updated Nomenclature for a Signature Optical Coherence Tomography Lesion Popovic, Marko M. MD, MPH; et. al. Retina 45(8):p 1451-1459, August 2025 https://t.co/CrBOTUIWBA
#retina
@PopovicMM
1
4
4
ADAPTIVE OPTICS IN RETINITIS PIGMENTOSA Mihalache, Andrew MD(C); et. al. Retina 45(7):p 1375-1388, July 2025 https://t.co/S9RFgmM0OY
#retina
@AndrewMihalache @RSTHuang @PopovicMM @BrianBallios @RaHMu123
0
5
1
Thank you ABC News Australia @abcnews for interviewing me about our study on GLP1 drugs and macular degeneration! Was a pleasure discussing this study with you! Link:
abc.net.au
GLP-1 agonists, like Ozempic and Wegovy, have been heralded as miracle drugs. They started out as diabetes drugs, but have shown benefits well beyond diabetes – including in weight loss and other...
0
0
7
Thank you @Bloomberg for featuring our study on the association between GLP-1 drugs and macular degeneration! https://t.co/9YdlzuveU8
bloomberg.com
Hi, it’s Michelle in New York. You may have heard of “Ozempic blindness,” when obesity drugs are linked to rare vision loss. Does this discovery change the risk-benefit analysis for the drugs? More...
1
1
4
Most viewed this week from @JAMAophth: More than twice as many patients with diabetes exposed to glucagon-like peptide-1 receptor agonists developed neovascular age-related macular degeneration compared with matched controls. https://t.co/NZRAsLZ83j
0
5
11
QUANTITATIVE FLUORESCEIN ANGIOGRAPHY BIOMARKERS IN DIABETIC MACULAR EDEMA Huang, Ryan S. MSc, MD(C); et. al. Retina 45(6):p 1125-1133, June 2025 https://t.co/W92XM3gxzp
#retina
@RSTHuang @AndrewMihalache @PopovicMM @RaHMu123
1
7
6
NEW STUDY: More than twice as many diabetic patients exposed to GLP-1 RAs (Ozempic, Wagovy, Mounjaro) developed age-related macular degeneration https://t.co/IYAYud82L6
119
453
2K
A new study suggests GLP-1 medicines such as Ozempic are associated with greater risk of developing age-related macular degeneration. Read more via @guardian @PopovicMM, @RaHMu123, @RaHMu123
@AndrewMihalache, @NooriAtefeh, @RKohly
https://t.co/ilH9k97Ry8
theguardian.com
Study finds medicines such as Ozempic associated with greater risk of developing age-related macular degeneration
0
2
2
More than twice as many patients with diabetes exposed to glucagon-like peptide-1 receptor agonists developed neovascular age-related macular degeneration compared with matched controls. https://t.co/TCXnrXbb8X
2
5
9
The potential risk of age-related macular degeneration with GLP-1 drugs in people with diabetes https://t.co/BoGo9iTutV
14
76
259
Dr. @PopovicMM (@uoftmedicine)'s study on preoperative fasting for ambulatory #Cataract surgery: a time-interrupted prospective study (The PRACTICE Study): https://t.co/DOWnQY2t5w
#VisionHealthMonth #EyeHealth
psifoundation.org
Grants & Awards funded by PSI Foundation
1
1
4
SOCIAL DETERMINANTS OF HEALTH IN AGE-RELATED MACULAR DEGENERATION A Nationally Representative Survey Study Huang, Ryan S.; et. al. Retina 45(4):p 703-713, April 2025 https://t.co/MyCmDDIGTl
#retina
@RSTHuang @AndrewMihalache @Jim_XCS @PopovicMM @RaHMu123 @RKohly @UofTDOVS
0
5
6
Infants receiving ranibizumab more likely to require re-treatment but had lower refractive error, with no significant difference in complication rates compared to infants who received laser photocoagulation (GRADE: moderate-low). https://t.co/WlogS92mLz
@a_baiad7 @popovicMM
0
3
12
While most ophthalmology journals have adopted guidelines on generative artificial intelligence (GenAI), this study found variability in their scope and comprehensiveness. https://t.co/tmvZ1TXXX0
0
6
22
Our latest analysis in @AAOjournal shows no difference in disease regression between laser photocoagulation and intravitreal ranibizumab for patients with retinopathy of prematurity:
0
0
5
Face Masking and Risk of Post-Intravitreal Injection Endophthalmitis: A Network Meta-Analysis of 2.6 Million Injections https://t.co/yh4FQZwDBg
@UofTDOVS @brendantao @RSTHuang @AndrewMihalache @DenaZera @PopovicMM @Jim_SCX @kztoronto @RKohly @RaHMu123
0
10
14
In a large cohort of patients with advanced diabetic retinopathy, risk factors for loss to follow-up were younger age, better visual acuity, infrequent clinic visits, and history of PRP instead of anti-VEGF, our latest analysis in @JAMANetworkOpen shows:
jamanetwork.com
This cohort study investigates the sociodemographic and clinical factors associated with being lost to follow-up among individuals with proliferative diabetic retinopathy and diabetic macular edema...
1
2
6
Our recent analysis in @AAOjournal of over 2.6 million intravitreal injections shows that no-talking and physician masking policies may reduce sight-threatening endophthalmitis compared to standard care or universal masking: https://t.co/JEprKVaMhO
#retina #research
aaojournal.org
To compare face-masking protocols for post-intravitreal injection endophthalmitis (PIE) prophylaxis.
0
3
11